Dr. Jeffrey Gelblum, Senior Neurologist at First Choice Neurology educates patients about the risk of dementia and Alzheimer’s disease. Dr. Gelblum offers bi-weekly Lunch and Learn talks on Facebook LIVE […]
Dr. Jeffrey Gelblum Talks about Proton Pump Inhibitors and Your Risk of Dementia Read More »
Biogen is providing its new Alzheimer’s drug, Aduhelm, free to some patients due to slow reviews by Medicare. There is a division among doctors about whether Aduhelm, also known as aducanumab,
Biogen Offering Free Alzheimer’s Drug Aduhelm to Patients Read More »
First Choice Neurology is hosting a new series of Facebook Live events this month – COVID-19: Roadmap to Reopening. Jeffrey Gelblum, MD kicked off the series yesterday presenting “Re-engaging Older
On Monday, April 20, Dr. Jeffrey Gelblum will present a Facebook Live event at 12:30 (Eastern Time) to talk about COVID-19 and blood tests that are antibody positive. Dr. Gelblum
Am I Safe if My COVID-19 Blood Test is Antibody Positive? Read More »
Written by Jeffrey Gelblum, MD A “Virtual Neurology Office” is a fully functional neurology office accessible online via new Telehealth technology. The physicians of First Choice Neurology have pioneered the
If you or a loved one are experiencing signs of early Alzheimer’s disease, there may soon be treatment and hope on the horizon. First Choice Neurology is participating in an
BAN2401 Study to Assess New Alzheimer’s Treatment Read More »
First Choice Neurology is launching the HAPPIN Study (Hereditary Amyloid Polyneuropathy Prevalence in Idiopathic Neuropathy). It is the nation’s first research study of the prevalence of hereditary amyloid neuropathy. Doctors
HAPPIN Study Seeks Patients with Idiopathic Neuropathy Read More »
What is Familial Amyloid Polyneuropathy? Familial Amyloid Polyneuropathy (FAP) is an inherited disease that causes progressive sensorimotor and autonomic nerve disorder. Peripheral nerve degeneration (polyneuropathy) begins in small fibers, resulting
